ClinicalTrialsFinder
RecruitingNot ApplicableNCT07365553

Omega-3, Autism Spectrum Disorder (ASD)

Omega-3 Fatty Acids and Autism Spectrum Disorder (ASD) - A Double-blind Randomized Controlled Trial of Omega-3 Fatty Acids in Youth With ASD

Sponsor

China Medical University Hospital

Enrollment

50 participants

Start Date

Jul 15, 2022

Study Type

INTERVENTIONAL

Conditions

ASD

Summary

This is a 12 week study to investigate the effects of omega-3 polyunsaturated fatty acids (PUFAs) in youth with autism spectrum disorder (ASD).

Eligibility

Min Age: 6 YearsMax Age: 17 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Omega-3 and Placebo for people with asd. The study is currently recruiting participants at 1 location. People eligible for this study include aged 6 Years to 17 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTOmega-3

Omega-3 PUFAs

DIETARY_SUPPLEMENTPlacebo

Soybean Oil

Locations(1)

China Medical University

Taichung, Taichung, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07365553

Related Trials

Trial of Center-Based vs. In-Home Pivotal Response Treatment (PRT) in Autism

NCT048995441 location

Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study

NCT073044401 location

Comprehensive Toileting Program

NCT072267391 location

GAIP ASD Research Study

NCT076223162 locations

Spironolactone Improved Children With Gene Mutations Related to NCOR

NCT066786851 location